{"id":"NCT00104234","sponsor":"BioMarin Pharmaceutical","briefTitle":"Study of rhASB in Patients With Mucopolysaccharidosis VI","officialTitle":"A Multicenter, Multinational Open-Label Extension Study of Recombinant Human N-acetylgalactosamine 4-sulfatase (rhASB) in Patients With Mucopolysaccharidosis VI","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2004-02","primaryCompletion":"2006-10","completion":"2006-10","firstPosted":"2005-02-25","resultsPosted":"2009-03-06","lastUpdate":"2010-02-02"},"enrollment":39,"design":{"allocation":"NON_RANDOMIZED","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Mucopolysaccharidosis VI"],"interventions":[{"type":"DRUG","name":"N-acetylgalactosamine 4-sulfatase","otherNames":["rhASB"]},{"type":"DRUG","name":"Placebo/rhASB","otherNames":[]}],"arms":[{"label":"rhASB/rhASB","type":"OTHER"},{"label":"Placebo/rhASB","type":"OTHER"}],"summary":"The purpose of this study is to evaluate the long-term efficacy and safety of rhASB treatment in patients with Mucopolysaccharidosis VI.","primaryOutcome":{"measure":"12-Minute Walk Test","timeFrame":"Baseline of ASB-03-05 through week 96 of ASB-03-06","effectByArm":[{"arm":"rhASB/rhASB","deltaMin":187,"sd":187},{"arm":"Placebo/rhASB","deltaMin":118,"sd":127}],"pValues":[]},"eligibility":{"minAge":"7 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":3},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["33874971"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":14,"n":38},"commonTop":["Cough","Headache","Pyrexia","Diarrhoea","Athralgia"]}}